Randomized phase II study comparing two schedules of everolimus in patients with recurrent/metastatic breast cancer: NCIC Clinical Trials Group IND.163. (Q43290574)
Jump to navigation
Jump to search
scientific article published on 17 August 2009
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Randomized phase II study comparing two schedules of everolimus in patients with recurrent/metastatic breast cancer: NCIC Clinical Trials Group IND.163. |
scientific article published on 17 August 2009 |
Statements
Randomized phase II study comparing two schedules of everolimus in patients with recurrent/metastatic breast cancer: NCIC Clinical Trials Group IND.163 (English)
Karen A Gelmon
Brian Norris
Hagen Kennecke
Stephen Chia
Andrea Eisen
Ted Vandenberg
Marianne Taylor
Eric Sauerbrei
Moshe Mishaeli
David Huntsman
Wendy Walsh
Martin Olivo
Lynn McIntosh
Lesley Seymour
17 August 2009